ÍNDICE ROX EM PACIENTES COM COVID-19 QUE USARAM TERAPIA DE ALTO FLUXO E ELMO

Conteúdo do artigo principal

Francisco Cleiton Ribeiro Freitas
Riany de Sousa Sena
Antonio Salvandi de Oliveira Junior
Ana Karine Castelo Branco de Paula Gomes
Lisandra Serra Damasceno

Resumo

Avaliar o índice ROX na monitorização de pacientes com insuficiência respiratória por COVID-19. Estudo transversal realizado no Hospital de Doenças Infecciosas São José, no Ceará. Foram incluídos indivíduos com COVID-19, internados no período de janeiro a julho, que utilizaram terapia de alto fluxo de oxigênio (TAF) combinado com ELMO. A coleta de dados ocorreu através da revisão de prontuários. Os dados foram analisados através do software Excel Microsoft 365. No período do estudo, 40 pacientes foram incluídos nesta pesquisa.  A maioria era do sexo masculino (67,5%). A média de idade foi de 51,9 anos; 65% dos pacientes obtiveram sucesso com a terapia TAF/ELMO. Índice ROX foi preditor de sucesso ou falha na 24ª e 48ª hora. Houve uma forte correlação entre o índice ROX e a PaO2/FiO2 final.  Baixos valores do índice ROX foram associados a um maior risco de intubação. 

Detalhes do artigo

Como Citar
1.
Ribeiro Freitas FC, de Sousa Sena R, Salvandi de Oliveira Junior A, Castelo Branco de Paula Gomes AK, Serra Damasceno L. ÍNDICE ROX EM PACIENTES COM COVID-19 QUE USARAM TERAPIA DE ALTO FLUXO E ELMO . Cadernos ESP [Internet]. 7º de dezembro de 2021 [citado 10º de agosto de 2022];15(2):17-22. Disponível em: //cadernos.esp.ce.gov.br/index.php/cadernos/article/view/671
Seção
Artigos Originais
Biografia do Autor

Riany de Sousa Sena, Universidade de Fortaleza

Universidade de Fortaleza. Hospital São Jose (HSJ).

Referências

Ranzani OT, Bastos LSL, Gelli JGM, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407-418. doi:10.1016/S2213-2600(20)30560-9

Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020;323(16):1545-1546. doi:10.1001/jama.2020.4031

Calligaro GL, Lalla U, Audley G, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. EClinicalMedicine. 2020 Nov;28:100570. doi: 10.1016/j.eclinm.2020.100570.

Vianello A, Arcaro G, Molena B, Turato C, Sukthi A, Guarnieri G. High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection. Thorax. 2020 Nov;75(11):998–1000. doi: 10.1136/thoraxjnl-2020-214993.

Franco C, Facciolongo N, Tonelli R, Dongilli R, Vianello A, Pisani L. Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia. Eur Respir J. 2020 Nov 5;56(5) doi: 10.1183/13993003.02130-2020.

Patel M, Gangemi A, Marron R, Chowdhury J, Yousef I, Zheng M. Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure. BMJ Open Respir Res. 2020 Aug;7(1) doi: 10.1136/bmjresp-2020-000650.

Vega ML, Pisani L. Nasal high flow oxygen in acute respiratory failure. Pulmonology. 2021 Feb 13 doi: 10.1016/j.pulmoe.2021.01.005. S2531-0437(21)00038-6https://doi.org/Epubahead of print.

Tonetti T, Grasselli G, Zanella A, Pizzilli G, Fumagalli R, Piva S. COVID-19 Northern Italian ICU Network. Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy. Ann Intens Care. 2020 Oct 12;10(1):133. doi: 10.1186/s13613-020-00750-z.

Coppadoro, A., Benini, A., Fruscio, R. et al. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care. 2021; 25:80.

Holanda MA, Tomaza BS, Menezesa DGA, Linoa JA, Gomesa GC. ELMO 1.0: a helmet interface for CPAP and high-flow oxygen delivery. J Bras Pneumol. 2021;47(3):e20200590.

Nishimura M. High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects. Respiratory Care. 2016; 61(4): 529-54.

Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intens Care Med. 2015 Apr;41(4):623–632. doi: 10.1007/s00134-015-3693-5.

Suliman LA, Abdelgawad TT, Farrag NS, Abdelwahab HW. Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia. Adv Respir Med. 2021;89(1):1-7. doi: 10.5603/ARM.a2020.0176.

Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: the utility of the ROX index. J Crit Care. 2016 Oct;35:200–205. doi: 10.1016/j.jcrc.2016.05.022.

Blez D, Soulier A, Bonnet F, et al. Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate. Intensive Care Med. 2020; 46(11): 2094–2095.

Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016; 35: 200–205.

Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019; 199(11): 1368–1376.

Hill NS, Ruthazer R. Predicting outcomes of high-flow nasal cannula for acute respiratory distress syndrome. An index that ROX. Am J Respir Crit Care Med. 2019; 199(11): 1300–1302.

Rodriguez M, Thille AW, Boissier F, et al. Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: a retrospective monocenter study. Ann Intensive Care. 2019; 9(1): 101.

Hu M, Zhou Q, Zheng R, Li X, Ling J, Chen Y, Jia J, Xie C. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study. BMC Pulm Med. 2020 Dec 24;20(1):324. doi: 10.1186/s12890-020-01354-w

Artigos mais lidos pelo mesmo(s) autor(es)